Cargando…
Ascending the PEAK1 toward targeting TGFβ during cancer progression: Recent advances and future perspectives
Cancer is the second leading cause of death in the United States. Mortality in patients with solid, epithelial-derived tumors strongly correlates with disease stage and the systemic metastatic load. In such cancers, notable morphological and molecular changes have been attributed to cells as they pa...
Autores principales: | Runa, Farhana, Adamian, Yvess, Kelber, Jonathan A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5790177/ https://www.ncbi.nlm.nih.gov/pubmed/29392163 http://dx.doi.org/10.14800/ccm.1162 |
Ejemplares similares
-
Fibronectin, DHPS and SLC3A2 Signaling Cooperate to Control Tumor Spheroid Growth, Subcellular eIF5A1/2 Distribution and CDK4/6 Inhibitor Resistance
por: Geller, Cameron, et al.
Publicado: (2023) -
ITGA1 is a pre-malignant biomarker that promotes therapy resistance and metastatic potential in pancreatic cancer
por: Gharibi, Armen, et al.
Publicado: (2017) -
PEAK1 Acts as a Molecular Switch to Regulate Context-Dependent TGFβ Responses in Breast Cancer
por: Agajanian, Megan, et al.
Publicado: (2015) -
Recent Progress and Future Perspectives of Immunotherapy in Advanced Gastric Cancer
por: Jin, Xin, et al.
Publicado: (2022) -
Recent advances in understanding contextual TGFβ signaling
por: Ayyaz, Arshad, et al.
Publicado: (2017)